| ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ... European heart journal 32 (23), 2999-3054, 2011 | 5119 | 2011 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 2046 | 2022 |
| Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations G Curigliano, D Lenihan, M Fradley, S Ganatra, A Barac, A Blaes, ... Annals of Oncology 31 (2), 171-190, 2020 | 969 | 2020 |
| Myocardial bridging JR Alegria, J Herrmann, DR Holmes Jr, A Lerman, CS Rihal European heart journal 26 (12), 1159-1168, 2005 | 672 | 2005 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 652 | 2020 |
| Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia J Herrmann Nature Reviews Cardiology 17 (8), 474-502, 2020 | 569 | 2020 |
| Evaluation and management of patients with heart disease and cancer: cardio-oncology J Herrmann, A Lerman, NP Sandhu, HR Villarraga, SL Mulvagh, M Kohli Mayo Clinic Proceedings 89 (9), 1287-1306, 2014 | 543 | 2014 |
| High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid … G Theilmeier, C Schmidt, J Herrmann, P Keul, M Schäfers, I Herrgott, ... Circulation 114 (13), 1403-1409, 2006 | 496 | 2006 |
| Peri-procedural myocardial injury: 2005 update J Herrmann European heart journal 26 (23), 2493-2519, 2005 | 479 | 2005 |
| Ubiquitin and ubiquitin-like proteins in protein regulation J Herrmann, LO Lerman, A Lerman Circulation research 100 (9), 1276-1291, 2007 | 451 | 2007 |
| Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement J Herrmann, D Lenihan, S Armenian, A Barac, A Blaes, D Cardinale, ... European heart journal 43 (4), 280-299, 2022 | 430 | 2022 |
| 5-fluorouracil and cardiotoxicity: a review JD Sara, J Kaur, R Khodadadi, M Rehman, R Lobo, S Chakrabarti, ... Therapeutic advances in medical oncology 10, 1758835918780140, 2018 | 403 | 2018 |
| Vascular toxicities of cancer therapies: the old and the new–an evolving avenue J Herrmann, EH Yang, CA Iliescu, M Cilingiroglu, K Charitakis, A Hakeem, ... Circulation 133 (13), 1272-1289, 2016 | 362 | 2016 |
| Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering SH Wilson, J Herrmann, LO Lerman, DR Holmes Jr, C Napoli, EL Ritman, ... Circulation 105 (4), 415-418, 2002 | 350 | 2002 |
| Glycolytic stimulation is not a requirement for M2 macrophage differentiation F Wang, S Zhang, I Vuckovic, R Jeon, A Lerman, CD Folmes, PP Dzeja, ... Cell metabolism 28 (3), 463-475. e4, 2018 | 349 | 2018 |
| Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo C Von Birgelen, W Klinkhart, GS Mintz, A Papatheodorou, J Herrmann, ... Journal of the American College of Cardiology 37 (7), 1864-1870, 2001 | 345 | 2001 |
| Coronary microvascular dysfunction in the clinical setting: from mystery to reality J Herrmann, JC Kaski, A Lerman European heart journal 33 (22), 2771-2783, 2012 | 315 | 2012 |
| Myocardial infarction due to percutaneous coronary intervention A Prasad, J Herrmann New England Journal of Medicine 364 (5), 453-464, 2011 | 308 | 2011 |
| Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia J Herrmann, LO Lerman, M Rodriguez-Porcel, DR Holmes Jr, ... Cardiovascular research 51 (4), 762-766, 2001 | 307 | 2001 |
| SCAI expert consensus statement: evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (Endorsed by the … CA Iliescu, CL Grines, J Herrmann, EH Yang, M Cilingiroglu, K Charitakis, ... Catheterization and cardiovascular interventions 87 (5), E202-E223, 2016 | 300 | 2016 |
